10-Q
GENESIS BIOPHARMA FORM 10-Q
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Filed
- August 14, 2012
- Period of Report
- June 30, 2012
- Accession Number
- 0001513160-12-000056
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →